• linkedin
  • Increase Font
  • Sharebar

    Severe pain after male sling implantation results in lawsuit

    Patient alleges physician had financial interest in product used for procedure


    Scarring from penile injections

    A 49-year-old New York man who suffered from erectile dysfunction presented to his physician and was prescribed an oral medication. Soon after that, the same physician prescribed an injectable treatment.

    Read: Is your scribe raising your risk of a malpractice lawsuit?

    When the patient was seen for a follow-up, he complained of two unsuccessful injections and another physician noticed scarring on the penis. The original physician attributed this scarring to the patient’s diabetes. The original physician prescribed another injectable formula, which also did not have favorable results. He saw the physician three more times within a 6-month period, each time leaving with a different formula to try.

    The man sued the original physician and alleged that he did not give the formulas time to work before changing to a different one, and that he should have been referred to a urologist when the scarring occurred.

    Also see - Informed consent: A medicolegal guide for urologists

    The physician argued that the scarring was attributable to the patient’s diabetes and not the injections or the change of the formulas. The jury returned a verdict for the patient and awarded $2 million, including $500,000 for past pain and suffering and $1.5 million for future pain and suffering.

    Next: Failure to remove fragment from penile implant

    Dawn Collins, JD
    MS COLLINS is an attorney specializing in medical malpractice in Long Beach, California. She welcomes feedback on this column via ...


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available